Synthetic Cannabinoids in UK Prisons and Beyond: Why Drug-Soaked Paper Is Driving a New Overdose Crisis

In October 2026, reports from Michigan described a wave of overdoses inside state prisons linked to a single, deceptively ordinary item: paper soaked in synthetic cannabinoid solution. The story is not isolated. Across the United States and increasingly in the United Kingdom and Europe, drug-soaked paper has become one of the most efficient — and most dangerous — ways to move and consume synthetic cannabinoids such as those found in K2 and Spice products.

For anyone who follows K2 herbal incense and the wider synthetic cannabinoid market, this development matters. It shows how the same chemistry that underpins infused herbal blends can be transferred to paper, card and other absorbent materials — with even less control over dose. This article explains what drug-soaked paper is, why it is spreading, how it connects to the herbal incense sector, and what the health and legal implications are for the UK and Europe.

What Is Drug-Soaked Paper?

Drug-soaked paper is exactly what the name suggests: a sheet of paper, card or similar absorbent material that has been treated with a solution containing a psychoactive substance, then dried. In the case of synthetic cannabinoids, the active compound is typically dissolved in a solvent such as acetone or ethanol, applied to the paper, and left to evaporate. What remains is a thin, often invisible residue of highly potent cannabinoid.

The finished product can look like an ordinary letter, a greetings card, a sheet of A4, or a page torn from a notebook. That camouflage is the point. In prisons and other controlled environments, where searches focus on powders, tablets and plant material, treated paper can pass through inspection with relative ease. Once inside, it is smoked, chewed or otherwise consumed.

This is not a new idea. The liquid K2 on paper format has circulated in the UK and Europe for years, and the herbal incense market has long understood that synthetic cannabinoids can be infused into absorbent carriers. What has changed is the scale and the consequences. The Michigan prison overdoses illustrate how a single batch of treated paper can poison dozens of people in a confined setting.

Why Paper Is Such an Effective — and Dangerous — Delivery Method

1. Dose control is almost impossible

Synthetic cannabinoids are active at milligram and sometimes microgram doses. When a compound is dissolved and sprayed or brushed onto paper, the distribution is rarely uniform. One corner of a sheet may carry far more active ingredient than another. A user who tears off a section has no reliable way of knowing how much they are about to consume.

This is the same problem that makes herbal incense blends so unpredictable, but it is amplified on paper. Herbal material at least offers visible bulk and a rough sense of quantity. A treated sheet offers neither. The result is a high risk of accidental overdose, even for experienced users.

2. The product is easy to conceal and transport

Paper is flat, light and innocuous. It can be posted, folded into a book, or carried in a pocket without attracting attention. In custodial settings, this makes it a preferred vehicle for contraband. In the community, it lowers the barrier to distribution and makes interception by authorities far harder.

3. Potency varies wildly between batches

The synthetic cannabinoid market is not a regulated pharmaceutical supply chain. Batches vary in the identity and concentration of the active compound. A sheet treated with one substance at one concentration may behave very differently from a sheet that looks identical. Users have no way to test or verify what they have.

4. The route of administration intensifies effects

Smoking treated paper delivers the compound rapidly to the lungs and bloodstream. Onset is fast, peak effects are intense, and the margin between a desired effect and a medical emergency is narrow. This is a recurring theme in synthetic cannabinoid poisoning, where rapid loss of consciousness, seizures and cardiovascular instability are common.

What the Michigan Prison Overdoses Tell Us

The Michigan cases, reported in October 2026, involved multiple overdoses in state prisons linked to drug-soaked paper. The pattern is familiar to toxicologists and prison health staff: a cluster of severe reactions, often within a short window, among people who consumed from the same batch.

Several features of these events are worth highlighting:

• Clustering: Overdoses arrive in groups because a single treated sheet is shared among multiple users.
• Severity: Synthetic cannabinoids can cause seizures, agitation, vomiting, chest pain and loss of consciousness, sometimes requiring hospital-level care.
• Unpredictability: Even people who have used synthetic cannabinoids before can be caught out by a stronger or differently formulated batch.
• Environmental risk: Staff and emergency responders may be exposed to residue or contaminated materials, complicating the response.

These features are not unique to prisons. They apply wherever treated paper circulates — in homeless shelters, in community settings, and among people who use synthetic cannabinoids recreationally.

The UK and Europe: A Familiar Pattern in a Different Setting

The UK has its own long history with synthetic cannabinoids. The Psychoactive Substances Act 2016 reshaped the legal landscape, and subsequent legislation brought many individual compounds under the Misuse of Drugs Act. Yet the market adapted. Products moved online, packaging changed, and new compounds appeared faster than legislation could keep pace.

In Europe, the picture is similarly fluid. The EU’s early warning system has flagged hundreds of new psychoactive substances over the past decade, a significant proportion of them synthetic cannabinoids. The K2 herbal incense market in Europe has shown a consistent ability to evolve around controls, and paper-based formats are part of that evolution.

What the Michigan cases add is a reminder that the delivery method matters as much as the substance. A compound that is dangerous in a herbal blend can be even more dangerous when applied to paper, because the dose is less visible and less controllable.

How Drug-Soaked Paper Connects to the Herbal Incense Sector

It is important to be clear about the relationship. Herbal incense products and drug-soaked paper are not the same thing, but they share a common chemistry and a common risk profile. Both rely on synthetic cannabinoids that are active at very low doses. Both are difficult to standardise outside a regulated manufacturing environment. Both can produce severe adverse effects when potency is higher than expected.

For readers who want to understand the underlying science, our guide to synthetic cannabinoids explained covers how these compounds interact with CB1 and CB2 receptors, why they can be far more potent than THC, and why the effects are not simply a stronger version of cannabis.

The paper format also raises a specific concern for the herbal incense sector: it blurs the line between products that are presented as aromatic or research materials and products that are clearly being used as drugs. That blurring invites tighter regulation, which affects legitimate suppliers and consumers alike.

Health Risks: What Drug-Soaked Paper Can Do to the Body

The health risks of synthetic cannabinoids are well documented and extend well beyond the immediate high. Key concerns include:

Acute toxicity

Nausea, vomiting, tachycardia, chest pain, agitation, confusion, seizures and loss of consciousness are all recognised effects of synthetic cannabinoid toxicity. In severe cases, users can require intensive care.

Mental health effects

Psychosis, paranoia, anxiety and panic are reported with synthetic cannabinoids, sometimes in people with no prior history of mental illness. The mental health risks of K2 and Spice are a significant concern for clinicians and harm-reduction workers.

Cardiovascular and neurological events

Case reports describe arrhythmias, myocardial infarction, stroke and seizures following synthetic cannabinoid use. The rapid onset associated with smoking treated paper increases the likelihood of these events.

Dependence and withdrawal

Synthetic cannabinoids can produce tolerance and dependence. Withdrawal symptoms include cravings, irritability, insomnia, sweating and, in some cases, severe agitation. Our article on synthetic cannabinoid withdrawal explores this in more detail.

Legal Status in the UK and Europe

In the UK, most synthetic cannabinoids are controlled under the Misuse of Drugs Act 1971, and the Psychoactive Substances Act 2016 provides additional coverage for substances not individually listed. Supplying, possessing with intent to supply, or importing controlled synthetic cannabinoids carries serious penalties.

In Europe, the legal picture varies by country. Some member states have adopted generic or class-based bans, while others rely on individual listings or consumer protection laws. The EU’s drug agency continues to monitor new compounds and coordinate responses. For a detailed overview, see our guide to synthetic cannabinoid legislation in the UK and Europe.

Drug-soaked paper does not create a legal loophole. If the paper contains a controlled substance, it is treated as a controlled substance. The format may make detection harder, but it does not change the underlying legal status.

Harm Reduction and Practical Safety

For people who encounter drug-soaked paper — whether as users, family members, prison staff or healthcare workers — a few principles are worth keeping in mind:

• Assume the dose is unknown. There is no safe way to estimate how much active compound is on a given piece of paper.
• Do not use alone. If someone is going to use, having another person present who can call for help is a meaningful risk reduction.
• Recognise the emergency signs. Seizures, unresponsiveness, severe agitation, chest pain and difficulty breathing require urgent medical attention.
• Avoid mixing substances. Combining synthetic cannabinoids with alcohol, benzodiazepines or other depressants increases the risk of respiratory and cardiovascular complications.
• Seek support for dependence. Synthetic cannabinoid dependence is treatable, and specialist services exist in the UK and across Europe.

For a broader overview of the risks associated with these compounds, our article on synthetic cannabinoid health risks is a useful starting point.

Frequently Asked Questions

What is drug-soaked paper?

Drug-soaked paper is paper or card that has been treated with a solution containing a psychoactive substance, such as a synthetic cannabinoid, and then dried. It is consumed by smoking, chewing or other routes.

Is drug-soaked paper the same as herbal incense?

No. Herbal incense typically involves plant material infused with aromatic or other compounds, while drug-soaked paper uses paper as the carrier. However, both can involve synthetic cannabinoids and share similar risk profiles.

Why are synthetic cannabinoids on paper so dangerous?

The dose is difficult to control, the distribution of the compound across the paper is uneven, and the potency of different batches varies widely. Smoking delivers the compound rapidly, increasing the risk of severe effects.

Are synthetic cannabinoids legal in the UK?

Most synthetic cannabinoids are controlled under UK drug law. The Psychoactive Substances Act 2016 also covers substances that are not individually listed. Possession, supply and import can all carry serious penalties.

What should I do if someone has a bad reaction to drug-soaked paper?

Call emergency services immediately. Keep the person safe, do not leave them alone, and provide as much information as possible about what was taken. Do not attempt to induce vomiting or give other substances.

Conclusion

The Michigan prison overdoses are a stark reminder that the synthetic cannabinoid problem is not static. As controls tighten on one format, the market adapts to another. Drug-soaked paper is the latest example of that adaptability — and it carries the same core risks that make K2, Spice and related products so dangerous: unpredictable potency, rapid onset, and a narrow margin between intoxication and medical emergency.

For consumers, suppliers and policymakers in the UK and Europe, the lesson is consistent. Understanding the chemistry, respecting the legal framework, and prioritising harm reduction are not optional extras. They are the minimum requirements for engaging with this market responsibly.